Brief: Hua Medicine Says Business Ops In China Impacted By Outbreak Of Novel Coronavirus Since Latter Half Of Jan
March 16 (Reuters) - Hua Medicine 2552.HK :
* HUA MEDICINE - BUSINESS OPERATIONS IN CHINA IMPACTED BY
OUTBREAK
OF NOVEL CORONAVIRUS SINCE LATTER HALF OF JAN
* HUA MEDICINE- FY ADJUSTED NET LOSS RMB 350.9 MILLION
VERSUS LOSS
OF RMB279.3 MILLION
* HUA MEDICINE - EXPECT POTENTIAL DELAYS IN RELEASE OF
TOP-LINE
RESULTS, POTENTIAL DELAYS WITH SOME NDA-ENABLING WORK DUE TO
COVID-19
Source text for Eikon: ID:nHKS5srXqk
Further company coverage: 2552.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hua Medicine
See all newsBrief: Hua Medicine Expects Loss Of RMB30.2 Mln For HY
Brief: Hua Medicine Posts Profit For The Year RMB1.11 Billion
Brief: Hua Medicine Says Dorzagliatin Approved For Marketing In Hong Kong SAR
Brief: Hua Medicine Posts H1 Revenue Of RMB 217.4 Million
Brief: Hua Medicine Expects RMB1,184.1 Million Profit For HY